INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

8602	Companies
140724	Keywords
76684	Articles
75195	Press releases

Home
Companies
INVENTIVA

BRIEF

published on 01/24/2025 at 22:05, 2 months 14 days ago

Half-yearly report on Inventiva's liquidity contract with Kepler Cheuvreux

Liquidity Contract Kepler Cheuvreux Biopharmaceutical Stock Market Transactions Inventiva
PRESS RELEASE

published on 01/24/2025 at 22:00, 2 months 14 days ago

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Inventiva announces half-year liquidity contract review with Kepler Cheuvreux. Cash and shares available in the liquidity account disclosed. Company focuses on developing oral small molecule therapies for MASH and unmet medical needs

Liquidity Contract Kepler Cheuvreux Clinical-Stage Biopharmaceutical Inventiva MASH
BRIEF

published on 01/22/2025 at 22:05, 2 months 16 days ago

Inventiva's LEGEND Trial Results to be Presented at EASL SLD Summit 2025

Lanifibranor Empagliflozin LEGEND Trial MASH Treatment EASL Summit 2025
PRESS RELEASE

published on 01/22/2025 at 22:00, 2 months 16 days ago

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025
Inventiva announces selection of LEGEND trial results evaluating lanifibranor and empagliflozin for oral presentation at EASL SLD Summit 2025, showing positive outcomes in MASH patients with T2D

Inventiva MASH Lanifibranor Empagliflozin LEGEND Trial
BRIEF

published on 12/17/2024 at 22:05, 3 months 21 days ago

Inventiva to present at the JP Morgan Healthcare Conference

Investors Inventiva NASH Lanifibranor JP Morgan Healthcare
PRESS RELEASE

published on 12/17/2024 at 22:00, 3 months 21 days ago

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference with CEO Frédéric Cren providing a corporate overview and engaging in investor meetings

Biopharmaceutical Inventiva J.P. Morgan Healthcare Conference Frédéric Cren Metabolic Dysfunction
BRIEF

published on 12/12/2024 at 22:05, 3 months 26 days ago

Inventiva Announces Shareholders’ Meeting Vote Results

Voting Results Shareholders' Meeting Biopharmaceutical Resolutions Inventiva
PRESS RELEASE

published on 12/12/2024 at 22:00, 3 months 26 days ago

Results of the votes of the Combined Shareholders’ General Meeting of December 11, 2024
Inventiva announces voting results of Combined Shareholders' General Meeting on December 11, 2024. All resolutions were adopted except the 59th resolution

Voting Results Shareholders' Meeting Clinical-Stage Biopharmaceutical Inventiva NASH
BRIEF

published on 11/21/2024 at 22:05, 4 months 16 days ago

Inventiva's Financial Overview for Q3 2024

Financial Results Cash Position Equity Raise Royalty Certificates R&D Expenses
PRESS RELEASE

published on 11/21/2024 at 22:00, 4 months 16 days ago

Inventiva reports 2024 Third Quarter Financial Information¹
Inventiva reports strong financial position with €13.9 million cash at September 30, 2024. R&D expenses down 10% in 2024. Key milestones and future conference participation announced

Financial Information Cash Position Inventiva R&D Expenses Key Milestones

Accesswire

Published on 04/08/2025 at 04:00, 2 hours 11 minutes ago

Leapmotor Selects QNX to Power New Electric SUV, the B10
Published on 04/07/2025 at 23:30, 6 hours 41 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 04/07/2025 at 23:30, 6 hours 41 minutes ago

Electric Metals Announces Private Placement Offering
Published on 04/07/2025 at 22:05, 8 hours 6 minutes ago

Vox Royalty Reports Major Financing Development at the Bullabulling Gold Project and Provides Western Australian Gold Sector Update
Published on 04/07/2025 at 22:05, 8 hours 6 minutes ago

Second Tranche Closing of US$4 Million Private Placement

View all ACCESSWIRE

EQS Group

Published on 04/07/2025 at 22:20, 7 hours 51 minutes ago

EQS-Adhoc: Infineon Technologies AG: Infineon Technologies AG enters agreement to buy Marvell Technology’s Automotive Ethernet business
Published on 04/07/2025 at 22:10, 8 hours 1 minute ago

Amrize Completes $3.4 Billion Bond Offering Ahead of Planned Spin-Off
Published on 04/07/2025 at 19:00, 11 hours 11 minutes ago

u-blox Divests Dual Mode Cellular-Satellite Communications Business to Trident IoT
Published on 04/07/2025 at 18:53, 11 hours 17 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/07/2025 at 18:06, 12 hours 5 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares

Les Echos

Published on 04/07/2025 at 18:00, 12 hours 11 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of March 28,2025
Published on 04/07/2025 at 17:59, 12 hours 12 minutes ago

Disclosure of trading in own shares between March 31st and April 4th, 2025
Published on 04/07/2025 at 17:45, 12 hours 26 minutes ago

Peugeot Invest publishes its 2024 Universal Registration Document
Published on 04/07/2025 at 17:45, 12 hours 26 minutes ago

Weekly share buyback
Published on 04/07/2025 at 17:35, 12 hours 36 minutes ago

Disclosure of transactions in own shares from April 1 to April 5, 2025

View all LES ECHOS COMFI WIRE